59
Participants
Start Date
January 22, 2024
Primary Completion Date
August 12, 2024
Study Completion Date
August 12, 2024
CHLOE
"the system will provide to the user a CHLOE™ score, which is a blastocyst development prediction value, a discrete grading for blastocyst associated with the likelihood of the embryo reaching the blastocyst stage at Day 5"
Weill Cornell Medicine, New York
Cleveland Clinic Fertility, Cleveland
Dallas Fertility Center, Dallas
Fairtility
INDUSTRY